Allogene Therapeutics Reports Second Quarter 2023 Financial

Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia , Canada , United States , American , Allogene Allo , Christine Cassiano , David Chang , Communications Officer , International Conference On Malignant Lymphoma , American Association Of Cancer Research , Allocart Program , American Society Of Clinical Oncology , Nasdaq , Linkedin , European Medicines Agency , European Hematology Association Congress , Allogene Therapeutics Inc , Drug Administration , Presented Long Term Data , Product Candidate , Refractory Largeb Cell Lymphoma , American Society , Clinical Oncology , Annual Meeting , International Conference , Malignant Lymphoma , Demonstrated Rates , Durable Complete Responses Similar , Approved Autologous , Complete Enrollment , First Data Readout Planned , Cash Equivalents , Net Proceeds , Equity Financing Facility During , Second Quarter , Cash Runway Now Projected , Webcast Scheduled , Allogene Therapeutics , Chief Executive Officer , Trial Application , American Association , Cancer Research , South San Francisco , Private Securities Litigation Reform Act , Exclusive License , Collaboration Agreement , Annual Report , Quarterly Report , Months Ended June , Investor Contact ,